Mytide Therapeutics Patents

Patent portfolio assigned to Mytide Therapeutics (verified via public assignee records). Estimated patent count: 1. Boston, MA (USA) automated peptide/biopolymer manufacturing + ML. Patent WO2020252266A1 'A manufacturing process for peptide and protein production' lists Mytide Therapeutics as original assignee (Google Patents). Competitors are peptide-synthesis peers from industry/aggregator sources; no named customers disclosed.